Spots Global Cancer Trial Database for A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies
Official Title: A Phase II Study of Deoxycoformycin (DCF) in Lymphoid Malignancies
Study ID: NCT00038025
Interventions
Study Description
Brief Summary: The purpose of this study is to determine the side effects and antitumor response of patients with lymphoid malignancies to Deoxycoformycin (DCF)/Pentostatin.
Detailed Description: Deoxycoformycin(DCF)/Pentostatin is a T-cell cytotoxic drug with previously reported responses in lymphoid malignancies but larger studies are needed.
Eligibility
Minimum Age: 16 Years
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
M. D. Anderson Cancer Center, Houston, Texas, United States
Contact Details
Name: Razelle Kurzrock, MD
Affiliation: MD Anderson
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
